Buchi N. Nalluri
About
In The Last Decade
Buchi N. Nalluri
62 papers receiving 725 citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Pharmaceutical Science 415
- Analytical Chemistry 135
- Molecular Biology 133
- Spectroscopy 107
- Materials Chemistry 98
Countries citing papers authored by Buchi N. Nalluri
This map shows the geographic impact of Buchi N. Nalluri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Buchi N. Nalluri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Buchi N. Nalluri more than expected).
Fields of papers citing papers by Buchi N. Nalluri
This network shows the impact of papers produced by Buchi N. Nalluri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Buchi N. Nalluri. The network helps show where Buchi N. Nalluri may publish in the future.
Co-authorship network of co-authors of Buchi N. Nalluri
This figure shows the co-authorship network connecting the top 25 collaborators of Buchi N. Nalluri. A scholar is included among the top collaborators of Buchi N. Nalluri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Buchi N. Nalluri. Buchi N. Nalluri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective breakdown → | 119 |
| 4 | 3 | |
| 5 | 13 | |
| 6 | 1 | |
| 7 | 8 | |
| 8 | 22 | |
| 9 | 13 | |
| 10 | Development of validated RP-HPLC-PDA method for the analysis of Capecitabine in bulk, dosage forms and in dissolution samples | 2 |
| 11 | Simultaneous estimation of lisinopril and hydrochlorthiazide in bulk, pharmaceutical dosage forms and in dissolution samples by RP-HPLC-PDA method | 1 |
| 12 | 2 | |
| 13 | Development And Validation Of A Sensitive Rp-Hplc-Pda Method For Assay Of Irbesartan In Pure And Pharmaceutical Dosage Forms | 5 |
| 14 | Studies on forced degradation of oxcarbazepine using LC-MS compatible stability indicating RP-HPLC method | 3 |
| 15 | 30 | |
| 16 | 17 | |
| 17 | 19 | |
| 18 | 144 | |
| 19 | 34 | |
| 20 | Microencapsulation Of Nifedipine - MCC Solvent Deposited System For Sustained Release | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.